Primary Site >> Liver Cancer

Gene >> TACC3

Journal: Oncologist. 2014 Mar;19(3):235-42.
Title: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
Author: Ross, Jeffrey S|Wang, Kai|Gay, Laurie|Al-Rohil, Rami|Rand, Janne V|Jones, David M|Lee, Hwa J|Sheehan, Christine E|Otto, Geoff A|Palmer, Gary|Yelensky, Roman|Lipson, Doron|Morosini, Deborah|Hawryluk, Matthew|Catenacci, Daniel V T|Miller, Vincent A|Churi, C
PMID: 24563076
Journal: Oncotarget. 2015 Sep 15;6(27):24163-77.
Title: TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.
Author: Zhou, Dong-Sheng|Wang, Hong-Bo|Zhou, Zhong-Guo|Zhang, Yao-Jun|Zhong, Qian|Xu, Li|Huang, Yue-Hua|Yeung, Sai-Ching|Chen, Min-Shan|Zeng, Mu-Sheng
PMID: 26219398
Journal: Tumour Biol. 2016 Jan;37(1):393-403.
Title: Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
Author: Nahm, Ji Hae|Kim, Haeryoung|Lee, Hyejung|Cho, Jai Young|Choi, Young Rok|Yoon, Yoo-Seok|Han, Ho-Seong|Park, Young Nyun
PMID: 26219896